Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
KULR Technology Group Inc KULR delivers 506 percent year over year revenue growth but shares drop 568 percent on sharp EPS miss TopBuild BLD Stock Jumps on Deal 572 20260418 TOYO Co TOYO Stock Exits Position Modest Uptick 20260418 John HPI Stock Trend Continuation Check John reports 137 EPS with no prerelease analyst estimates How Coherent COHR prepares for market disruptions Q1 2026 Earnings Underperform Biz First BFST Stock Why Cash Conversion 055 20260420 Armlogi BTOC Stock Downside Risk Overview Armlogi posts 013 EPS loss on 1904T revenue Biomea BMEA Stock Analysis Falls 699 Watching 126 20260515 Eltek ELTK Earnings Outlook Key Metrics for Q4 2025 Orchid Breeding The Secretive MultimillionDollar Industry with a DecadeLong Development Cycle ServisFirst Bancshares SFBS Q1 2026 Results Top Views on Strong Revenue Biotech and Pharma Stocks Slide as Rotation Into Energy Accelerates Silence SLN Q4 2024 Earnings Revenue NA Matching Views Cigna Group CI Downgraded to Hold by Deutsche Bank Over MultiYear Uncertainty Concerns Novartis Raises FullYear Sales and Profit Guidance Amid Strong Operational Performance Bitcoin Slips to 74500 Faces Weekly Loss Amid Rising Geopolitical Tensions Statista Projects US Employment and Unemployment Trends for 2031 Snowflake Stock Surges 36 on Earnings Beat and 6 Billion AWS Expansion Plan HarleyDavidson Analyst Report Highlights Market Position and Strategy MSA Q1 2026 Earnings EPS Beat Leads to Modest Share Price Gain Udemy Q1 2026 Earnings Deep EPS Miss Overshadows Quiet Market GPCR Q1 2026 Earnings NarrowerThanExpected Loss Fuels Positive Investor Sentiment Accenture Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Dip Cyngn Inc CYN Q1 2026 Earnings EPS Beat Amid Zero Revenue Stock Edges Lower NEWTG Q1 2026 Earnings EPS Misses Estimates Amid Slight Decline Inhibrx Biosciences INBX Surges Over 5 as Biotech Momentum Builds Vine Hill Capital Investment Corp II VHCP Modest Gain Reflects Stable Trading Near Trust Value Xilio Therapeutics XLO Shows Resilience with 191 Gain Approaching Key Resistance Riverview Bancorp RVSB Slides 211 as Support Level Tested Skye Bioscience Surges 77 Biotech Stock Tests Resistance at 081